-
Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 14, Status: Authorised
17 Feb 2025 17:20 GMT
… infections without bacteraemia, Daptomycin Hospira is given at a … associated with bacteraemia. Daptomycin Hospira is given by infusion … of treatment with Daptomycin Hospira depends on the risk … information about using Daptomycin Hospira, see the package leaflet …
-
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 15, Status: Authorised
16 Dec 2024 15:05 GMT
Pemetrexed Hospira is available as a powder … during treatment with Pemetrexed Hospira. When Pemetrexed Hospira is given with cisplatin …
-
Human medicines European public assessment report (EPAR): Topotecan Hospira, topotecan, Date of authorisation: 09/06/2010, Revision: 20, Status: Authorised
13 Dec 2024 14:14 GMT
Treatment with Topotecan Hospira should only be given under … low.
The dose of Topotecan Hospira to be used depends on … height. For lung cancer, Topotecan Hospira is given every day for … cisplatin in cervical cancer, Topotecan Hospira is given on days 1 …
-
Medical Fluid Bag Market Worth $6,057.60 million by 2030 With CAGR of 5.50% | Fresenius Kabi, Hospira, Pall Corporation
02 Sep 2024 13:08 GMT
… , Baxter International, ConvaTec, Fresenius Kabi, Hospira Inc., Pall Corporation, Smiths Medical …
-
Human medicines European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira), voriconazole, Date of authorisation: 27/05/2015, Revision: 14, Status: Authorised
23 Aug 2024 15:04 GMT
Voriconazole Hikma is an antifungal medicine used for the treatment of adults and children over the age of two years who have the following infections caused by a fungus:
invasive aspergillosis (a type of fungal infection due to Aspergillus);
candidaemia ( …
-
Large Volume Parenteral Market Current and Future Trends and Industry Forecast | Hospira, Patheon, Cook Pharmica LLC.
09 Aug 2024 12:21 GMT
… Pharmaceutical Inc.
◘ BAG Healthcare GmbH
◘ Hospira Inc.
◘ Patheon Inc.
◘ Otsuka Pharmaceutical …
-
Erythropoietin Drugs Market to Reach $14.41 Bn by 2032, Fueled by 5.7% CAGR: Johnson & Johnson, Amgen, Roche, Hospira
08 Jul 2024 12:58 GMT
… & Johnson
Amgen Inc.,
Roche, Hospira Inc.
Biocon
LG Life Sciences …
-
Hospira Recalls Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units
23 May 2024 15:10 GMT
… complaint of a leaking unit.
Hospira, a Pfizer company, announced on … in the release (2).
References
Hospira. Hospira Inc. Issues a Voluntary Nationwide … . Press Release. May 21, 2024.
Hospira. Hospira, Inc. Issues A Voluntary Nationwide …
-
Pfizer's Hospira recalls 5 injectable drug lots due to report of leak, potential seal issues
23 May 2024 19:24 GMT
… of leaking product, Pfizer’s Hospira unit is pulling five lots … notice posted by the FDA.
Hospira’s buprenorphine product is indicated …
-
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units
23 May 2024 10:14 GMT
Hospira, Inc., affiliated to dug major … , and quarantine the product immediately.
Hospira in October last year had …
About
© 1995-2025